News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
127 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Policy
TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR
The Company expects to learn of the acceptance of the NDA resubmission within 30 calendar days.
November 29, 2017
·
4 min read
BioMidwest
Apexian Pharmaceuticals is Closing a Series A Round to Initiate Phase I Trial
This financing follows previous investments as well as numerous grants and awards by the company since its founding.
November 29, 2017
·
3 min read
Revive Therapeutics Announces Successful Final Results of Novel Cannabinoid Delivery Technology Unlocking Commercialization Opportunities in the Medical Cannabis and Pharmaceutical Sectors
The Company is positioned to advance the development and commercialization of novel medical cannabis products and pharmaceutical cannabinoid therapies internally, with licensed medical cannabis producers, and pharmaceutical companies.
November 29, 2017
·
7 min read
Business
Concept Life Sciences Invests in East Kilbride Analytical Services Facility
Concept also plans to increase headcount at the site by 8 FTEs in order to support the increase in capacity and workload, in addition to the 7 FTEs that joined the team in 2017.
November 29, 2017
·
1 min read
Insightec: The TFDA Approved Exablate Neuro for the Treatment of Essential Tremor
The approval was based on data from a randomized, double-blind clinical study conducted in eight medical centers in North America and Asia.
November 29, 2017
·
2 min read
BioCapital
Oxford Finance Provides $20M Senior Debt Facility to VitalConnect
The funds are being used to further the commercialization of the VitalConnect solution suite for both hospital and remote patient monitoring markets.
November 29, 2017
·
3 min read
Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin
Bill & Melinda Gates Foundation invests in R&D pilot for anti-malarial active pharmaceutical ingredients.
November 29, 2017
·
3 min read
Business
Cullinan Oncology Adds Industry Leaders to Board, Bringing Significant Business & Healthcare Acumen
The company announced today the appointment of Thomas Ebeling and Tony Rosenberg to its Board of Directors.
November 29, 2017
·
2 min read
Dynatronics Holds Annual Meeting of Shareholders
Results of the voting and other information relating to the company’s Annual Meeting of Shareholders will be reported by the company in a Current Report on Form 8-K to be filed with the SEC.
November 29, 2017
·
3 min read
Genetown
Myomo Expands MyoPro Centers of Excellence Program
The additions to the CoE program build upon the Company’s footprint as it targets a presence in all the top metropolitan areas in the U.S.
November 29, 2017
·
4 min read
Previous
12 of 13
Next